PMID- 30687553 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220331 IS - 2090-2085 (Print) IS - 2090-2093 (Electronic) IS - 2090-2093 (Linking) VI - 2018 DP - 2018 TI - Assessing the Relationship between Performance on the University of California Performance Skills Assessment (UPSA) and Outcomes in Schizophrenia: A Systematic Review and Evidence Synthesis. PG - 9075174 LID - 10.1155/2018/9075174 [doi] LID - 9075174 AB - OBJECTIVE: To perform a systematic review of the published literature to evaluate how functional capacity, as measured by the University of California at San Diego (UCSD) Performance-based Skills Assessment (UPSA), relates to other functional measures and real-world outcomes among individuals with schizophrenia. METHODS: The MEDLINE(R) and Embase(R) databases were searched to identify joint evaluations with UPSA and key functional outcomes (functional scale measures; generic or disease-specific, health-related quality of life [HRQoL]; or real-world outcomes [residential status; employment status]) in patients with schizophrenia. Pearson correlations were estimated between UPSA scores, HRQoL, other functional scale measures, and real-world outcomes, for outcomes described in at least six studies. RESULTS: The synthesis included 76 studies that provided 73 unique data sets. Quantitative assessment between the Specific Level of Function (SLOF) (n=18) scores and UPSA scores demonstrated a moderate borderline-significant correlation (0.45, p=0.06). Quantitative analysis of the relationship between the Global Assessment of Functioning (GAF) (n=11) and the Multidimensional Scale of Independent Functioning (MSIF) (n=6) scales revealed moderate and small nonsignificant Pearson correlations of -0.34 (p=0.31) and 0.12 (p=0.83), respectively. There was a small borderline-significant correlation between UPSA score and residential status (n=36; 0.31; p=0.08), while no correlation was found between UPSA score and employment status (n=19; 0.04; p=0.88). CONCLUSION: The SLOF was the most often used functional measure and had the strongest observed correlation with the UPSA. Although knowledge gaps remain, evidence from this review indicates that there is a quantitative relationship between functional capacity and real-world outcomes in individuals with schizophrenia. FAU - Szabo, Shelagh AU - Szabo S AUID- ORCID: 0000-0002-9044-3192 AD - Broadstreet HEOR, Vancouver, BC, Canada. FAU - Merikle, Elizabeth AU - Merikle E AUID- ORCID: 0000-0002-3310-1196 AD - Takeda Pharmaceuticals, Deerfield, IL, USA. FAU - Lozano-Ortega, Greta AU - Lozano-Ortega G AUID- ORCID: 0000-0002-5378-0544 AD - Broadstreet HEOR, Vancouver, BC, Canada. FAU - Powell, Lauren AU - Powell L AD - Broadstreet HEOR, Vancouver, BC, Canada. FAU - Macek, Thomas AU - Macek T AD - Takeda Pharmaceuticals, Deerfield, IL, USA. FAU - Cline, Stephanie AU - Cline S AUID- ORCID: 0000-0002-9157-7782 AD - Takeda Pharmaceuticals, Deerfield, IL, USA. LA - eng PT - Journal Article PT - Review DEP - 20181227 PL - Egypt TA - Schizophr Res Treatment JT - Schizophrenia research and treatment JID - 101576450 PMC - PMC6327277 EDAT- 2019/01/29 06:00 MHDA- 2019/01/29 06:01 PMCR- 2018/12/27 CRDT- 2019/01/29 06:00 PHST- 2018/05/24 00:00 [received] PHST- 2018/11/12 00:00 [revised] PHST- 2018/12/05 00:00 [accepted] PHST- 2019/01/29 06:00 [entrez] PHST- 2019/01/29 06:00 [pubmed] PHST- 2019/01/29 06:01 [medline] PHST- 2018/12/27 00:00 [pmc-release] AID - 10.1155/2018/9075174 [doi] PST - epublish SO - Schizophr Res Treatment. 2018 Dec 27;2018:9075174. doi: 10.1155/2018/9075174. eCollection 2018.